Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Osteoclasts: what do they do and how do they do it?Teitelbaum SLAm J Pathol 2007[Feb]; 170 (2): 427-35As Americans live longer, degenerative skeletal diseases, such as osteoporosis, become increasingly prevalent. Regardless of cause, osteoporosis reflects a relative enhancement of osteoclast activity. Thus, this unique bone resorptive cell is a prominent therapeutic target. A number of key observations provide insights into the mechanisms by which precursors commit to the osteoclast phenotype and how the mature cell degrades bone. The osteoclast is a member of the monocyte/macrophage family that differentiates under the aegis of two critical cytokines, namely RANK ligand and M-CSF. Tumor necrosis factor (TNF)-alpha also promotes osteoclastogenesis, particularly in states of inflammatory osteolysis such as that attending rheumatoid arthritis. Once differentiated, the osteoclast forms an intimate relationship with the bone surface via the alphavbeta3 integrin, which transmits matrix-derived, cytoskeleton-organizing, signals. These integrin-transmitted signals include activation of the associated proteins, c-src, syk, Vav3, and Rho GTPases. The organized cytoskeleton generates an isolated microenvironment between the cell's plasma membrane and the bone surface in which matrix mineral is mobilized by the acidic milieu and organic matrix is degraded by the lysosomal protease, cathepsin K. This review focuses on these and other molecules that mediate osteoclast differentiation or function and thus serve as candidate anti-osteoporosis therapeutic targets.|Aging/*metabolism/pathology[MESH]|Arthritis, Rheumatoid/metabolism/pathology/therapy[MESH]|Cell Differentiation[MESH]|Cytoskeleton/metabolism/pathology[MESH]|Extracellular Matrix/metabolism[MESH]|Humans[MESH]|Inflammation/metabolism/pathology[MESH]|Macrophage Colony-Stimulating Factor/*metabolism[MESH]|Osteoclasts/*metabolism/pathology[MESH]|Osteolysis/*metabolism/pathology/therapy[MESH]|Osteoporosis/metabolism/pathology/therapy[MESH]|Peptide Hydrolases/metabolism[MESH]|Protein Kinases/metabolism[MESH]|RANK Ligand/*metabolism[MESH]|Receptors, Tumor Necrosis Factor/metabolism[MESH]|Signal Transduction[MESH]|Tumor Necrosis Factor-alpha/*metabolism[MESH] |
